Log in Request access

Caplight Directory

Rambam AG

Overview

Rambam AG is a Swiss-based venture studio and accelerator platform focused on breakthrough drug discovery and development.

Year Founded

2021

Portfolio Companies

1

Website

Investments

Company	Date	Stage	Lead
NeurOdys Therapeutics	Mar 2026	Pre Seed	Lead

Key People

Rouslan Michtchenko

Global Executive Director

Sanja Tomovska

Venture Partner Strategic Growth EU

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium

SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium

2021

2022

2023

2024

2025

2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersZug

Year Founded2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

Use CasesInvestors Employees

CompaniesAll Companies

LegalPrivacy Policy Terms of Use BrokerCheck Form CRS

Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.